These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6611960)

  • 1. [Membrane transport of anticancer drugs--potentiation of antitumor effect by calcium modifiers and overcoming of drug-resistance].
    Tsuruo T
    Tanpakushitsu Kakusan Koso; 1983 May; 28(6):865-71. PubMed ID: 6611960
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1982 Nov; 42(11):4730-3. PubMed ID: 7127307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
    Vilpo J; Koski T; Vilpo L
    Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by calcium antagonist of coupling of insulin binding and insulin action on glucose transport in isolated fat cells.
    Ishibashi F; Kubo K
    Hiroshima J Med Sci; 1984 Mar; 33(1):73-9. PubMed ID: 6384143
    [No Abstract]   [Full Text] [Related]  

  • 6. [Calcium antagonist enhances the effect of adriamycin].
    Matsuoka H; Ueo H; Sugimachi K; Kai H; Matsuura H
    Nihon Geka Gakkai Zasshi; 1985 Apr; 86(4):508. PubMed ID: 4000105
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin.
    Epstein PM; Fiss K; Hachisu R; Andrenyak DM
    Biochem Biophys Res Commun; 1982 Apr; 105(3):1142-9. PubMed ID: 6284165
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of the antihypertensive drug felodipine with calmodulin.
    Bostróm SL; Ljung B; Mårdh S; Forsen S; Thulin E
    Nature; 1981 Aug; 292(5825):777-8. PubMed ID: 7266647
    [No Abstract]   [Full Text] [Related]  

  • 9. Circumvention of resistance to anthracyclines by calcium antagonists and other membrane-perturbing agents.
    Kessel D
    Cancer Surv; 1986; 5(1):109-27. PubMed ID: 3297311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulators of multidrug resistance. Preclinical studies.
    Ford JM
    Hematol Oncol Clin North Am; 1995 Apr; 9(2):337-61. PubMed ID: 7642467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reversal of antitumor drug resistance by modification of membrane transport].
    Tsuruo T
    Seikagaku; 1983 Oct; 55(10):1198-203. PubMed ID: 6400391
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium and calmodulin antagonists binding to calmodulin and relaxation of coronary segments.
    Johnson JD; Fugman DA
    J Pharmacol Exp Ther; 1983 Aug; 226(2):330-4. PubMed ID: 6875846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of dihydropyridine calcium channel blockers with calmodulin and calmodulin inhibitors.
    Thayer SA; Fairhurst AS
    Mol Pharmacol; 1983 Jul; 24(1):6-9. PubMed ID: 6865927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
    Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
    Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Overcoming the multiple drug resistance of tumors].
    Donenko FV; Sitdikova SM; Moroz LV
    Vopr Onkol; 1991; 37(11-12):1034-41. PubMed ID: 1688278
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of nicardipine on airway dynamics during general anesthesia].
    Kinoshita H; Sakai T; Ohsumi A; Yano H; Yoshida H; Fukui A; Fukutomi O; Takaori M
    Masui; 1985 May; 34(5):588-94. PubMed ID: 4032687
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enhanced cytotoxicity of VM-26 in human malignant glioma cells by calcium channel blocker nicardipine in vitro].
    Hu S; Huang C; Chen B
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):143-6. PubMed ID: 11938773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium antagonist as biological modulator in cancer chemotherapy].
    Tsuruo T
    Nihon Rinsho; 1989 Aug; 47(8):1851-6. PubMed ID: 2573744
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of nicardipine hydrochloride on hemodynamics and regional myocardial functions in experimental coronary ischemia].
    Bando S; Kakutani A; Shinomiya H; Noda T; Minezono K; Mori H
    Kokyu To Junkan; 1983 Aug; 31(8):875-80. PubMed ID: 6658218
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.